글로벌 광학 이미징 시장 – 2031년까지의 산업 동향 및 예측

광학 이미징 시장 분석 및 규모

광학 이미징 시장에서 연구개발(R&D)은 혁신과 응용 분야를 확장하는 데 중요한 역할을 합니다. 최첨단 R&D 노력은 광 간섭 단층촬영(OCT), 형광 이미징, 다중 광자 현미경과 같은 이미징 기술을 개선하고 해상도, 속도 및 정확도를 높이는 데 중점을 둡니다. 이러한 발전은 세포 및 분자 프로세스를 보다 자세히 시각화하여 질병을 이해하고 새로운 치료법을 개발하는 데 획기적인 진전을 이룹니다. 광학 이미징 분야의 R&D는 또한 특수 이미징 에이전트와 프로브를 생성하여 이미징 모달리티의 기능을 더욱 향상시킵니다.

글로벌 광학 이미징 시장 규모는 2023년에 23억 1,000만 달러로 평가되었으며, 2031년까지 59억 7,000만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 12.60%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

보고 범위 및 시장 세분화       

시장 정의

광학 이미징은 가시광선, 자외선, 적외선을 포함한 빛을 사용하여 조직, 세포 및 생물학적 구조의 자세한 이미지를 캡처하는 기술입니다. 고해상도 이미지와 기능 정보를 비침습적으로 제공할 수 있기 때문에 의료 진단 및 연구에 널리 사용됩니다. 광 간섭 단층 촬영(OCT) 및 형광 이미징과 같은 기술은 광학 이미징의 일반적인 응용 분야입니다.

광학 이미징 시장 동향

운전자                                                                                          

• 노인 인구 증가

황반변성, 백내장, 심혈관 질환, 신경퇴행성 질환과 같은 연령 관련 건강 상태의 유병률 증가. 노인 인구가 증가함에 따라 이러한 만성 질환을 효과적으로 관리하기 위한 고급 진단 및 모니터링 도구에 대한 필요성이 커지고 있습니다. 광 간섭 단층촬영(OCT) 및 형광 이미징과 같은 광학 이미징 기술은 이러한 질환의 조기 발견 및 지속적인 모니터링에 이상적인 비침습적 고해상도 이미징 솔루션을 제공합니다. 결과적으로, 고령 인구의 의료 요구에 따라 의료 진단 및 치료 모니터링에서 광학 이미징 시스템에 대한 수요가 증가할 것으로 예상됩니다.

• 만성 질환의 유병률 증가

The rising prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, requires a precise and early diagnosis for effective management, and the demand for advanced imaging technologies, such as optical coherence tomography (OCT) and fluorescence imaging increased. Optical imaging provides high-resolution, non-invasive visualization of tissues, aiding in early detection, monitoring disease progression, and evaluating treatment efficacy. The growing burden of chronic diseases underscores the need for reliable diagnostic tools, thereby propelling the adoption and growth of optical imaging technologies in healthcare.

Opportunities

• Rising Technological Advancements

Technological advancements have led to significant improvements in imaging techniques and devices. Innovations such as enhanced optical coherence tomography (OCT), advanced fluorescence imaging, and multiphoton microscopy have increased the resolution, speed, and accuracy of imaging, enabling more detailed and precise visualization of biological structures. These technological improvements make optical imaging tools more effective for diagnostic and research applications, expanding their use in medical fields and beyond. The integration of artificial intelligence and machine learning with optical imaging technologies further enhances image analysis and interpretation, driving market growth by offering more sophisticated and reliable imaging solutions.

• Expanding Healthcare Expenditure

As governments and private sectors allocate more funds to healthcare, there is increased investment in advanced diagnostic technologies, including optical imaging. This financial support enhances the accessibility and adoption of sophisticated imaging systems in hospitals and clinics, improving patient care. Higher healthcare spending also facilitates the upgrade of existing medical infrastructure and encourages research and development activities, leading to innovations in optical imaging. Consequently, the growing healthcare budgets across the globe directly contribute to the expansion and advancement of the optical imaging market.

Restraints/Challenges

• High Maintenance Costs

High maintenance costs impacts both healthcare providers and manufacturers. Optical imaging systems require regular maintenance to ensure optimal performance and reliability, which can involve costly service contracts, spare parts, and specialized technical expertise. These expenses add to the initial investment and total cost of ownership, making it challenging for healthcare facilities, especially smaller ones or those in resource-limited settings, to afford and sustain these technologies. Moreover, high maintenance costs can deter potential buyers from upgrading or expanding their imaging capabilities, limiting market growth and adoption rates of optical imaging solutions globally.

• Competing Imaging Modalities

Competing imaging modalities such as MRI (magnetic resonance imaging), CT (computed tomography) scans, and ultrasound often offer higher resolution and greater depth penetration for specific diagnostic applications compared to optical imaging methods such as optical coherence tomography (OCT) or fluorescence imaging. Moreover, healthcare providers may be more familiar with and have established workflows for these modalities, making them reluctant to switch to newer optical imaging technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In October 2023, Leica Microsystems announced the official opening of its USD 60 million medical manufacturing and R&D facility in Singapore. As one of Leica's four global production sites, Singapore is solely responsible for manufacturing surgical microscopes for export to global markets. This facility enhances Leica's production capacity and strengthens its presence in the Asia-Pacific region
• In October 2023, Abbott launched a new vascular imaging platform driven by Ultreon 1.0 Software in India. This software combines optical coherence tomography (OCT) with artificial intelligence (AI), providing physicians with a comprehensive view of blockages and blood flow in coronary arteries. The platform aims to improve diagnostic accuracy and patient outcomes in cardiovascular care
• In September 2023, Revvity released several next-generation preclinical imaging technologies across multiple applications in preclinical research. The new innovations include the IVIS SpectrumCT 2 and the next-generation IVIS Spectrum 2 imaging systems, which enhance sensitivity standards and versatility in in vivo optical imaging. These advancements aim to improve research outcomes in preclinical studies
• In August 2023, Abbott announced its ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) clinical study, which demonstrated that intravascular imaging through optical coherence tomography (OCT) can enhance stent procedural outcomes, particularly in complex cases. The study showed that OCT guidance resulted in a statistically significant 7% increase in minimal stent area (MSA) compared to angiography guidance alone, indicating better procedural success

Optical Imaging Market Scope

The market is segmented on the basis of technique, therapeutic area, application, end user and product. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Imaging Systems
• Cameras
  • Optical Imaging Systems
  • Spectral Imaging Systems
• Illumination Systems
• Lenses
• Other Optical Imaging Products

Technique                                                                         

• Coherence Tomography
• Near-Infrared Spectroscopy
• Hyperspectral Imaging
• Photoacoustic Tomography
• Diffused Optical Tomography
• Super Resolution Microscopy

Therapeutic area

• Ophthalmology
• Oncology
• Cardiology
• Dermatology
• Neurology
• Dentistry
• Others

Application 

• Pre-Clinical and Clinical Research
• Pathological Imaging
• Intra-Operative Imaging

End User

• Hospitals
• Radiology Clinics
• Ambulatory Imaging Centres
• Research Laboratories
• Pharmaceutical and Biotechnology Companies
• Diagnostic Imaging Centres

Optical Imaging Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, technique, therapeutic area, application, end user and product as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.

North America dominates the market due to its robust research infrastructure, abundant skilled professionals, and rapid adoption of advanced technologies. The region benefits from less stringent regulatory frameworks, lower research costs, and substantial government funding, which collectively facilitate innovation and market growth in optical imaging technologies. These factors contribute to North America's prominent position in driving advancements and applications in this field compared to other regions.

Asia-Pacific is expected to grow in the market growth due to rapid technological advancements in healthcare infrastructure, increasing healthcare expenditure, and growing adoption of advanced medical imaging technologies are driving demand. Moreover, expanding research and development activities in countries such as China, Japan, and India are further boosting market expansion. Additionally, the rising prevalence of chronic diseases and a growing geriatric population requiring advanced diagnostic tools contribute to the region's projected rapid growth in the optical imaging market.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 다운스트림 및 업스트림 가치 사슬 분석, 기술 트렌드 및 포터의 5가지 힘 분석, 사례 연구와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 몇 가지 포인터입니다. 또한 글로벌 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 광학 이미징 시장 분석

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 활동하는 주요 기업은 다음과 같습니다.

• 필립스 헬스케어(네덜란드)
• Cerner Corporation (미국)
• 지멘스 헬시니어스(독일)
• 맥케슨 코퍼레이션(미국)
• 후지필름 홀딩스 주식회사(일본)
• 메디카 그룹 주식회사(영국)
• Agfa Healthcare(벨기에)
• 미라다 메디컬(미국)
• ONRAD Inc. (미국)
• RamSoft Inc. (캐나다)
• NovaRad Corporation(미국)
• TeleDiagnostic Solutions Pvt. Ltd. (인도)
• Teleradiology Solutions(인도)
• Telerad Tech(인도)
• StatRad LLC(미국)
• MedWeb LLC(미국)
• WebRad TeleRadiology(인도)
• NautilU.S. Medical (미국)
• 4ways Healthcare(영국)
• USARAD Holdings, Inc. (미국)
• GE 헬스케어(미국)

SKU-1663